ESTRO 35 Programme book
11:05 > Modelling of secondary cancer risks Speaker: U. Schneider (Switzerland)
SP-0437
11:25 > Clinical implications of secondary cancer risks in pediatric and adult patients Speaker: D. Hodgson (Canada)
MONDAY 2 MAY 2016
SP-0438
Proffered Papers RADIOBIOLOGY 4: MOLECULAR BIOMARKERS FOR PATIENT SELECTION
10:45 - 11:45 | LONDRA Chair: C. West (UK) Chair: M. De Jong (The Netherlands)
10:45 > Localization of p16 expression is an important factor to determine radiotherapy response in HNSCC R. Dok (Belgium), L. Abbasi Asbagh, E. Van Limbergen, A. Sablina, S. Nuyts 10:55 > Impact of chemokine receptor CXCR4 and its ligand SDF1 expression on loco-regional control in HNSCC A. Menegakis (Germany), C. De Colle, D. Moennich, F. Fend, P.S. Mauz, S. Welz, I. Tinhofer, V. Budach, E. Gkika, M. Stuschke, P. Balermpas, C. Roedel, M. Avlar, A.L. Grosu, A. Abdollahi, J. Debus, C. Bayer, C. Belka, S. Pigorsch, S.E. Combs, M. Krause, M. Baumann, D. Zips 11:05 > Genomic amplification of FancA in HNSCC: mechanisms of radioresis- tance and clinical relevance 11:15 > Does miR-210 predict benefit from hypoxia modification in BCON randomised bladder cancer patients? C. West (UK), J. Irlam-Jones, A. Eustance, H. Denley, P. Hoskin, A. Choudhury 11:25 > Radiotherapy sensitivity in breast cancer is influenced by the DNA cyto- sine deaminase APOBEC3B P.N. Span (The Netherlands), A. Post, J.W.M. Martens, R.S. Harris J. Hess (Germany), I. Gimenez Aznar, A. Michna, D. Klein, U. Schötz, M. Orth, L. Schneider, H. Braselmann, L. Schüttrumpf, V. Jendrossek, C. Belka, V. Zangen, K. Unger, H. Zitzelsberger, K. Lauber
OC-0439
OC-0440
OC-0441
OC-0442
OC-0443
INTERDISCIPLINARY RADIOBIOLOGY
CLINICAL BRACHYTHERAPY PHYSICS
RTT
YOUNG
SCIENTIFIC PROGRAMME | PROGRAMME AND EXHIBITION GUIDE
128
Made with FlippingBook